<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="18/11/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8663148" creator="Junko Matsuura">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>8663148</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">A <term sem="Protein_molecule" id="A1">3&apos; --&gt; 5&apos; XPB helicase</term> defect in <term sem="Protein_family_or_group" id="T3" lex="repair/transcription_factor">repair/transcription factor</term> <term sem="Protein_molecule" id="T4" lex="TFIIH">TFIIH</term> of xeroderma pigmentosum group B affects both <term sem="Other" id="T5" lex="DNA_repair">DNA repair</term> and <term sem="Other" id="T6" lex="transcription">transcription</term>.</sentence>
<event id="E1">
<type class="Negative_regulation" />
<theme idref="A1" />
<clue>A 3&apos; --&gt; 5&apos; XPB helicase <clueType>defect</clueType> <clueLoc>in repair/transcription factor TFIIH of xeroderma pigmentosum group B</clueLoc> affects both DNA repair and transcription.</clue>
<comment>NER: T1DEL, T2DEL</comment>
</event>
<event id="E2">
<type class="Regulation" />
<theme idref="T5" />
<cause idref="E1" />
<clue>A 3&apos; --&gt; 5&apos; XPB helicase defect in repair/transcription factor TFIIH of xeroderma pigmentosum group B <clueType>affects</clueType> both DNA repair and transcription.</clue>
</event>
<event id="E3">
<type class="Regulation" />
<theme idref="T6" />
<cause idref="E1" />
<clue>A 3&apos; --&gt; 5&apos; XPB helicase defect in repair/transcription factor TFIIH of xeroderma pigmentosum group B <clueType>affects</clueType> both DNA repair and transcription.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term sem="Protein_molecule" id="T7" lex="XPB">XPB</term> is a subunit of the basal <term sem="Protein_family_or_group" id="T8" lex="transcription_factor">transcription factor</term> <term sem="Protein_molecule" id="T9" lex="TFIIH">TFIIH</term>, which is also involved in <term sem="Other" id="A2">nucleotide excision repair (NER)</term> and potentially in <term sem="Other" id="A3">cell cycle regulation</term>.</sentence>
<event id="E4">
<type class="Correlation" />
<theme idref="T7" />
<theme idref="A2" />
<clue>XPB is a subunit of the basal transcription factor TFIIH, which is also <clueType>involved</clueType> <linkTheme>in</linkTheme> nucleotide excision repair (NER) and potentially in cell cycle regulation.</clue>
</event>
<event id="E5">
<type class="Correlation" />
<theme idref="T7" />
<theme idref="A3" />
<clue>XPB is a subunit of the basal transcription factor TFIIH, which is also <clueType>involved</clueType> <linkTheme>in</linkTheme> nucleotide excision repair (NER) and potentially in cell cycle regulation.</clue>
</event>
<sentence id="S3">A frameshift mutation in the 3&apos;-end of the <term sem="DNA_domain_or_region" id="T10" lex="XPB_gene"><term sem="Protein_molecule" id="T11" lex="XPB">XPB</term> gene</term> is responsible for a concurrence of two disorders: <term sem="Other" id="T12" lex="xeroderma_pigmentosum">xeroderma pigmentosum</term> (<term sem="Other" id="T13" lex="XP">XP</term>) and <term sem="Other" id="T14" lex="Cockayne&apos;s_syndrome">Cockayne&apos;s syndrome</term> (<term sem="Other" id="T15" lex="CS">CS</term>).</sentence>
<event id="E6">
<type class="Mutagenesis" />
<theme idref="T10" />
<clue>A <clueType>frameshift mutation</clueType> <linkTheme>in</linkTheme> the 3&apos;-end of the XPB gene is responsible for a concurrence of two disorders: xeroderma pigmentosum (XP) and Cockayne&apos;s syndrome (CS).</clue>
</event>
<event id="E7">
<type class="Positive_regulation" />
<theme idref="T13" />
<cause idref="E6" />
<clue>A frameshift mutation in the 3&apos;-end of the XPB gene is <clueType>responsible</clueType> <linkTheme>for</linkTheme> a concurrence of two disorders: xeroderma pigmentosum (XP) and Cockayne&apos;s syndrome (CS).</clue>
</event>
<event id="E8">
<type class="Positive_regulation" />
<theme idref="T15" />
<cause idref="E6" />
<clue>A frameshift mutation in the 3&apos;-end of the XPB gene is <clueType>responsible</clueType> <linkTheme>for</linkTheme> a concurrence of two disorders: xeroderma pigmentosum (XP) and Cockayne&apos;s syndrome (CS).</clue>
</event>
<sentence id="S4">We have isolated <term sem="Protein_molecule" id="T16" lex="TFIIH">TFIIH</term> from cells derived from a <term sem="Multicellular_organism_natural" id="T17" lex="patient">patient</term> (<term sem="Multicellular_organism_natural" id="T18" lex="XP11BE">XP11BE</term>) who carries this <term sem="Other" id="T19" lex="frameshift_mutation">frameshift mutation</term> (<term sem="Protein_molecule" id="T20" lex="TFIIHmut">TFIIHmut</term>) and from the <term sem="Multicellular_organism_natural" id="T21" lex="mother">mother</term> of this <term sem="Multicellular_organism_natural" id="T22" lex="patient">patient</term> (<term sem="Protein_molecule" id="T23" lex="TFIIHwt">TFIIHwt</term>) to determine the <term sem="Other" id="T24" lex="biochemical_consequence">biochemical consequences</term> of the mutation.</sentence>
<sentence id="S5">Although identical in composition and <term sem="Other" id="T25" lex="stoichiometry">stoichiometry</term> to <term sem="Protein_molecule" id="T26" lex="TFIIHwt">TFIIHwt</term>, <term sem="Protein_molecule" id="T27" lex="TFIIHmut">TFIIHmut</term> shows a reduced <term sem="Protein_molecule" id="A6">3&apos; --&gt; 5&apos; <term sem="Protein_molecule" id="T28" lex="XPB">XPB</term> helicase</term> activity.</sentence>
<event id="E9">
<type class="Negative_regulation" />
<theme idref="A6" />
<clue>Although identical in composition and stoichiometry to TFIIHwt, <clueLoc>TFIIHmut</clueLoc> shows a <clueType>reduced</clueType> 3&apos; --&gt; 5&apos; XPB helicase activity.</clue>
</event>
<sentence id="S6">A decrease in <term sem="Protein_molecule" id="A7">helicase</term> and <term sem="Other" id="T29" lex="DNA-dependent_ATPase_activity"><term sem="Protein_molecule" id="T30" lex="DNA-dependent_ATPase">DNA-dependent ATPase</term> activities</term> was also observed with the mutated recombinant <term sem="Protein_molecule" id="T31" lex="XPB_protein"><term sem="Protein_molecule" id="T32" lex="XPB">XPB</term> protein</term>.</sentence>
<event id="E10">
<type class="Negative_regulation" />
<theme idref="A7" />
<clue>A <clueType>decrease</clueType> <linkTheme>in</linkTheme> helicase and DNA-dependent ATPase activities was also observed <clueLoc>with the mutated recombinant XPB protein.</clueLoc></clue>
</event>
<event id="E11">
<type class="Negative_regulation" />
<theme idref="T30" />
<clue>A <clueType>decrease</clueType> <linkTheme>in</linkTheme> helicase and DNA-dependent ATPase activities was also observed <clueLoc>with the mutated recombinant XPB protein.</clueLoc></clue>
</event>
<event id="E12">
<type class="Mutagenesis" />
<theme idref="T31" />
<clue>A decrease in helicase and DNA-dependent ATPase activities was also observed with the <clueType>mutated</clueType> recombinant XPB protein.</clue>
<comment>Artificial</comment>
</event>
<sentence id="S7">The <term sem="Other" id="T33" lex="XPB_mutatio"><term sem="Protein_molecule" id="T34" lex="XPB">XPB</term> mutation</term> causes a <term sem="Other" id="T35" lex="severe_NER_defect">severe <term sem="Other" id="A8">NER</term> defect</term>.</sentence>
<event id="E13">
<type class="Mutagenesis" />
<theme idref="T34" />
<clue>The XPB <clueType>mutation</clueType> causes a severe NER defect.</clue>
<comment>Artificial</comment>
</event>
<event id="E14">
<type class="Negative_regulation" />
<theme idref="A8" />
<clue>The XPB mutation causes a severe NER <clueType>defect</clueType>.</clue>
</event>
<event id="E15">
<type class="Positive_regulation" />
<theme idref="E14" />
<cause idref="E13" />
<clue>The XPB mutation <clueType>causes</clueType> a severe NER defect.</clue>
</event>
<sentence id="S8">In addition, we provide evidence for a decrease in <term sem="Other" id="T36" lex="basal_transcription_activity">basal transcription activity</term> in vitro.</sentence>
<event id="E16">
<type class="Negative_regulation" />
<theme idref="T36" />
<cause idref="E13" />
<clue>In addition, we provide evidence for a <clueType>decrease</clueType> <linkTheme>in</linkTheme> basal transcription activity in vitro.</clue>
<comment>NO COREFCAUSE</comment>
</event>
<sentence id="S9">The latter defect may provide an explanation for many of the <cons sem="(AND Other Other)" id="C1" lex="(AND XP_symptom CS_symptom)"><frag id="F1">XP</frag> and <frag id="F2">CS</frag> <frag id="F3">symptoms</frag></cons> that are difficult to rationalize based solely on an <term sem="Other" id="T38" lex="NER_defect"><term sem="Other" id="A9">NER</term> defect</term>.</sentence>
<event id="E17">
<type class="Negative_regulation" />
<theme idref="A9" />
<clue>The latter defect may provide an explanation for many of the XP and CS symptoms that are difficult to rationalize based solely on an NER <clueType>defect</clueType>.</clue>
<comment>T37-&gt;C</comment>
</event>
<event id="E117">
<type class="Positive_regulation" />
<theme idref1="F3" idref="F1" />
<cause idref="E17" />
<clue>The latter defect may provide an explanation for many of the XP and CS symptoms that are difficult to rationalize <clueType>based</clueType> solely <linkCause>on</linkCause> an NER defect.</clue>
</event>
<event id="E118">
<type class="Positive_regulation" />
<theme idref1="F3" idref="F2" />
<cause idref="E17" />
<clue>The latter defect may provide an explanation for many of the XP and CS symptoms that are difficult to rationalize <clueType>based</clueType> solely <linkCause>on</linkCause> an NER defect.</clue>
</event>
<event uncertainty="probable" id="E18">
<type class="Positive_regulation" />
<theme idref1="F3" idref="F1" />
<cause idref="E16" />
<clue><corefTheme idref1="E16">The latter defect</corefTheme> may <clueType>provide an explanation</clueType> <linkTheme>for</linkTheme> many of the XP and CS symptoms that are difficult to rationalize based solely on an NER defect.</clue>
</event>
<event uncertainty="probable" id="E19">
<type class="Positive_regulation" />
<theme idref1="F3" idref="F2" />
<cause idref="E16" />
<clue><corefTheme idref1="E16">The latter defect</corefTheme> may <clueType>provide an explanation</clueType> <linkTheme>for</linkTheme> many of the XP and CS symptoms that are difficult to rationalize based solely on an NER defect.</clue>
</event>
<sentence id="S10">Thus, this work presents the first detailed analysis of a <term sem="Other" id="T39" lex="naturally_occurring_mutation">naturally occurring mutation</term> in a <term sem="Protein_family_or_group" id="T40" lex="basal_transcription_factor">basal transcription factor</term> and supports the concept that the combined <term sem="Other" id="T42" lex="XP/CS_clinical_entity"><term sem="Other" id="A15">XP</term>/<term sem="Other" id="T43" lex="CS">CS</term> clinical entity</term> is actually the result of a combined <term sem="Other" id="T44" lex="transcription/repair_deficiency"><term sem="Other" id="A13">transcription</term>/<term sem="Other" id="A14">repair</term> deficiency</term>.</sentence>
<event id="E20">
<type class="Mutagenesis" />
<theme idref="T40" />
<clue>Thus, this work presents the first detailed analysis of a naturally occurring <clueType>mutation</clueType> <linkTheme>in</linkTheme> a basal transcription factor and supports the concept that the combined XP/CS clinical entity is actually the result of a combined transcription/repair deficiency.</clue>
<comment>NER: T41 del &quot;transcription factor&quot;</comment>
</event>
<event id="E21">
<type class="Negative_regulation" />
<theme idref="A13" />
<clue>Thus, this work presents the first detailed analysis of a naturally occurring mutation in a basal transcription factor and supports the concept that the combined XP/CS clinical entity is actually the result of a combined transcription/repair <clueType>deficiency</clueType>.</clue>
</event>
<event id="E22">
<type class="Negative_regulation" />
<theme idref="A14" />
<clue>Thus, this work presents the first detailed analysis of a naturally occurring mutation in a basal transcription factor and supports the concept that the combined XP/CS clinical entity is actually the result of a combined transcription/repair <clueType>deficiency</clueType>.</clue>
</event>
<event id="E23">
<type class="Positive_regulation" />
<theme idref="T42" />
<cause idref="E21" />
<cause idref="E22" />
<clue>Thus, this work presents the first detailed analysis of a naturally occurring mutation in a basal transcription factor and supports the concept that the combined XP/CS clinical entity is actually the <clueType>result</clueType> <linkCause>of</linkCause> a combined transcription/repair deficiency.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
